Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Diabetes Complications. 2017 Mar 18;31(6):983–987. doi: 10.1016/j.jdiacomp.2017.03.005

Table 2. Results.

Comparison of Outcome Variables in Participants with T2DM and Controls

Characteristic Group
Statistical Value* P-value
People with T2DM
(n = 52)
Controls
(n = 29)
Right Shoulder g of Activity 2102 ± 773 2685 ± 1114 Z = 2.49 0.01
Duration of Right Shoulder Activity (Hours) 6.11 ± 1.77 6.92 ± 2.2 Z = 1.72 0.08
SIF (AU) 3.57 ± 1.74 2.68 ± 0.56 Z = 2.49 0.01
SIF (AU) Without participants with ≥ 30 pack years smoking 3.36 ± 1.32 n=46 2.68 ± 0.56 n=29 Z = 2.25 0.02
Total SPADI (%) 21.7 ± 21.3 1.8 ± 3.7 Z = 5.37 <0.01
SPADI Disability (%) 18.5 ± 19.9 1.2 ± 2.8 Z = 5.19 <0.01
SPADI Pain (%) 26.9 ± 26.0 2.6 ± 6.5 Z = 5.03 <0.01
Dominant Shoulder Active Flexion (°)# 145 ± 12 150 ± 10 t = 2.11 0.04
Dominant Shoulder Passive Flexion (°)# 159 ± 9 163 ± 11 t = 1.84 0.07
Dominant Shoulder External Rotation (°)# 88 ± 16 83 ± 9 t = 1.84 0.07
Dominant Shoulder Internal Rotation (°)# 51 ± 11 52 ± 8 Z = 0.16 0.88
Dominant Shoulder Flexion Strength (kg) 15.4 ± 5.0 18.4 ± 4.5 t = 2.72 0.01
Dominant Grip Strength (kg) 13.7 ± 4.7 14.9 ± 3.9 Z = 1.44 0.15
*

Independent t-tests were used when data were normally distributed (t-score); Mann Whitney U tests were used when data were not normally distributed in at least one group for each variable (Z-score).

Missing data for 1 participant with T2DM who was unable to wear accelerometer (n = 51)

P < 0.05

#

Measured as angle between humerus and thorax

AU = Arbitrary Units